Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12461746rdf:typepubmed:Citationlld:pubmed
pubmed-article:12461746lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:12461746lifeskim:mentionsumls-concept:C0555952lld:lifeskim
pubmed-article:12461746lifeskim:mentionsumls-concept:C0596263lld:lifeskim
pubmed-article:12461746lifeskim:mentionsumls-concept:C0879389lld:lifeskim
pubmed-article:12461746lifeskim:mentionsumls-concept:C0033413lld:lifeskim
pubmed-article:12461746lifeskim:mentionsumls-concept:C0025723lld:lifeskim
pubmed-article:12461746lifeskim:mentionsumls-concept:C1979963lld:lifeskim
pubmed-article:12461746lifeskim:mentionsumls-concept:C2003903lld:lifeskim
pubmed-article:12461746pubmed:issue1lld:pubmed
pubmed-article:12461746pubmed:dateCreated2002-12-3lld:pubmed
pubmed-article:12461746pubmed:abstractTextMethylation of the MLH1 promoter region has been suggested to be a principal mechanism of gene inactivation in sporadic microsatellite instability (MSI)-positive colorectal carcinoma. Recently, we have shown a novel methylation profile of the MLH1 promoter region (i.e., full, partial, and no methylation), among which full methylation was strongly associated with MSI. In this study, to confirm whether methylation requires the involvement of both alleles, we studied the MLH1 promoter region concerning the methylation profile and allelic loss. Furthermore, we studied correlations of methylation profiles with genetic alternations such as loss of heterozygosity (LOH) of the TP53 locus and KRAS mutation. Eighty-eight tumors were classified as full (n = 14), partial (n = 26), and no methylation (n = 48). Full methylation was observed in 78% (14/18) of high-frequency MSI, in which all CpG sites in the promoter region were methylated. Full methylation differed significantly from partial methylation regarding absence of TP53 LOH (0/12) and KRAS mutation (0/14). In cases with full methylation, we could show biallelic methylation by use of a single-base nucleotide polymorphism in the promoter. However, this did not accompany LOH of the MLH1 locus. In contrast, there were no significant differences in molecular features between partial and no methylation, except for low frequencies of LOH of the MLH1 locus (P = 0.02). In conclusion, biallelic extensive methylation of the MLH1 promoter region plays a significant role in gene inactivation and is independent of KRAS mutation and TP53 LOH.lld:pubmed
pubmed-article:12461746pubmed:languageenglld:pubmed
pubmed-article:12461746pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12461746pubmed:citationSubsetIMlld:pubmed
pubmed-article:12461746pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12461746pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12461746pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12461746pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12461746pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12461746pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12461746pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12461746pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12461746pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12461746pubmed:statusMEDLINElld:pubmed
pubmed-article:12461746pubmed:monthJanlld:pubmed
pubmed-article:12461746pubmed:issn1045-2257lld:pubmed
pubmed-article:12461746pubmed:authorpubmed-author:KonishiFumioFlld:pubmed
pubmed-article:12461746pubmed:authorpubmed-author:NagaiHideoHlld:pubmed
pubmed-article:12461746pubmed:authorpubmed-author:MaekawaMasato...lld:pubmed
pubmed-article:12461746pubmed:authorpubmed-author:SuganoKokichi...lld:pubmed
pubmed-article:12461746pubmed:authorpubmed-author:FukayamaNorik...lld:pubmed
pubmed-article:12461746pubmed:authorpubmed-author:MatsuiTakashi...lld:pubmed
pubmed-article:12461746pubmed:authorpubmed-author:KotakeKenjiro...lld:pubmed
pubmed-article:12461746pubmed:authorpubmed-author:MiyakuraYasuy...lld:pubmed
pubmed-article:12461746pubmed:authorpubmed-author:IgarashiSeiji...lld:pubmed
pubmed-article:12461746pubmed:authorpubmed-author:KoyamaYasuoYlld:pubmed
pubmed-article:12461746pubmed:copyrightInfoCopyright 2002 Wiley-Liss, Inc.lld:pubmed
pubmed-article:12461746pubmed:issnTypePrintlld:pubmed
pubmed-article:12461746pubmed:volume36lld:pubmed
pubmed-article:12461746pubmed:ownerNLMlld:pubmed
pubmed-article:12461746pubmed:authorsCompleteYlld:pubmed
pubmed-article:12461746pubmed:pagination17-25lld:pubmed
pubmed-article:12461746pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:meshHeadingpubmed-meshheading:12461746...lld:pubmed
pubmed-article:12461746pubmed:year2003lld:pubmed
pubmed-article:12461746pubmed:articleTitleMethylation profile of the MLH1 promoter region and their relationship to colorectal carcinogenesis.lld:pubmed
pubmed-article:12461746pubmed:affiliationDepartment of Surgery, Jichi Medical School, Tochigi, Japan.lld:pubmed
pubmed-article:12461746pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12461746pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12461746pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:4292entrezgene:pubmedpubmed-article:12461746lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12461746lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12461746lld:pubmed